A single lipoprotein(a) screening in a person’s lifetime could significantly reduce their risk for heart disease-related morbidity and mortality, yet this opportunity is often missed.Screening for elevated Lp(a) and targeting modifiable risk factors and lifestyle could meaningfully lower risk for atherosclerotic CVD and potentially thrombosis, even in people with very high levels.